246 related articles for article (PubMed ID: 27512842)
21. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP
Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566
[TBL] [Abstract][Full Text] [Related]
22. PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population.
Francès F; Verdú F; Portolés O; Castelló A; Sorlí JV; Guillen M; Corella D
Clin Chim Acta; 2008 Dec; 398(1-2):70-4. PubMed ID: 18786524
[TBL] [Abstract][Full Text] [Related]
23. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
Ye HD; Li YR; Hong QX; Zhou AN; Zhao QL; Xu LM; Xu MQ; Xu XT; Tang LL; Dai DJ; Jiang DJ; Huang Y; Wang DW; Duan SW
Genet Mol Res; 2015 Jun; 14(2):6350-9. PubMed ID: 26125839
[TBL] [Abstract][Full Text] [Related]
24. The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.
Xu W; Xu J; Sun B; Chen H; Wang Y; Huang F; Xi P; Jiang J
Mol Biol Rep; 2013 Feb; 40(2):875-84. PubMed ID: 23065280
[TBL] [Abstract][Full Text] [Related]
25. Associations between nine candidate genetic polymorphisms with coronary heart disease : A meta-analysis.
Li Q; Du Q
Herz; 2020 Dec; 45(Suppl 1):15-28. PubMed ID: 31041492
[TBL] [Abstract][Full Text] [Related]
26. PPARA, PPARD and PPARG gene polymorphisms in patients with unstable angina.
Maciejewska-Skrendo A; Pawlik A; Sawczuk M; Rać M; Kusak A; Safranow K; Dziedziejko V
Gene; 2019 Aug; 711():143947. PubMed ID: 31252163
[TBL] [Abstract][Full Text] [Related]
27. Lack of genetic associations between PPAR-γ gene rs1801282 polymorphism and Alzheimer's disease in general population: a meta-analysis.
Wu Y; Wu Q; Zhang H; Chen C; Chen G; Yang H; Qin D; Fu H
Gene; 2015 Jun; 563(2):120-4. PubMed ID: 25770052
[TBL] [Abstract][Full Text] [Related]
28. Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.
Lin B; Huang Y; Zhang M; Wang J; Wu Y
BMJ Open; 2014 Jan; 4(1):e004156. PubMed ID: 24430880
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
Skogsberg J; McMahon AD; Karpe F; Hamsten A; Packard CJ; Ehrenborg E;
J Intern Med; 2003 Dec; 254(6):597-604. PubMed ID: 14641801
[TBL] [Abstract][Full Text] [Related]
30. Case-control study on association of peroxisome proliferator-activated receptor-δ and SNP-SNP interactions with essential hypertension in Chinese Han population.
Li Y; Sun G
Funct Integr Genomics; 2016 Jan; 16(1):95-100. PubMed ID: 26613934
[TBL] [Abstract][Full Text] [Related]
31. Associations between PPARG polymorphisms and the risk of essential hypertension.
Cai G; Zhang X; Weng W; Shi G; Xue S; Zhang B
PLoS One; 2017; 12(7):e0181644. PubMed ID: 28727849
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses.
Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
Vasc Health Risk Manag; 2008; 4(2):427-36. PubMed ID: 18561518
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
34. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
35. PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.
González-Castro TB; Tovilla-Zárate CA; Juárez-Rojop IE; Hernández-Díaz Y; López-Narváez ML; Rodríguez-Pérez C; González-Hernández YK; Ramos-Méndez MÁ
Biomark Med; 2018 Mar; 12(3):287-297. PubMed ID: 29441810
[TBL] [Abstract][Full Text] [Related]
36. Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P; Wang Q; Yin Y; Yang Z; Li W; Liang D; Zhou P
J Atheroscler Thromb; 2015; 22(9):912-25. PubMed ID: 25832497
[TBL] [Abstract][Full Text] [Related]
37. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
38. Variants and expression changes in PPAR-encoding genes display no significant association with schizophrenia.
Li X; Zhu Y; Keaton M; Baranova A; Liu S; Hu X; Li Q; Cheng L; Zhou P; Cao H; Xu Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32643760
[TBL] [Abstract][Full Text] [Related]
39. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
Hui Y; Yu-Yuan L; Yu-Qiang N; Wei-Hong S; Yan-Lei D; Xiao-Bo L; Yong-Jian Z
Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
[TBL] [Abstract][Full Text] [Related]
40. PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Liu Y; Yuan Z; Liu Y; Zhang J; Yin P; Wang D; Wang Y; Kishimoto C; Ma A
Am Heart J; 2007 Oct; 154(4):718-24. PubMed ID: 17892998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
